nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranylcypromine—CYP2E1—Dacarbazine—sarcoma	0.182	0.223	CbGbCtD
Tranylcypromine—CYP2E1—Mitoxantrone—sarcoma	0.141	0.173	CbGbCtD
Tranylcypromine—CYP1A2—Dacarbazine—sarcoma	0.105	0.129	CbGbCtD
Tranylcypromine—CYP3A4—Thiotepa—sarcoma	0.0995	0.122	CbGbCtD
Tranylcypromine—CYP2E1—Etoposide—sarcoma	0.089	0.109	CbGbCtD
Tranylcypromine—CYP1A2—Etoposide—sarcoma	0.0515	0.0632	CbGbCtD
Tranylcypromine—CYP3A4—Mitoxantrone—sarcoma	0.0428	0.0525	CbGbCtD
Tranylcypromine—CYP3A4—Vincristine—sarcoma	0.0294	0.0361	CbGbCtD
Tranylcypromine—CYP2D6—Doxorubicin—sarcoma	0.0289	0.0355	CbGbCtD
Tranylcypromine—CYP3A4—Etoposide—sarcoma	0.027	0.0331	CbGbCtD
Tranylcypromine—CYP3A4—Doxorubicin—sarcoma	0.0184	0.0226	CbGbCtD
Tranylcypromine—Chills—Thiotepa—sarcoma	0.00108	0.00599	CcSEcCtD
Tranylcypromine—Chills—Dactinomycin—sarcoma	0.00107	0.00595	CcSEcCtD
Tranylcypromine—Blood disorder—Doxorubicin—sarcoma	0.00107	0.00593	CcSEcCtD
Tranylcypromine—Alopecia—Thiotepa—sarcoma	0.00107	0.0059	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Vincristine—sarcoma	0.00106	0.00589	CcSEcCtD
Tranylcypromine—Bradycardia—Mitoxantrone—sarcoma	0.00106	0.00587	CcSEcCtD
Tranylcypromine—Alopecia—Dactinomycin—sarcoma	0.00106	0.00586	CcSEcCtD
Tranylcypromine—Haemoglobin—Mitoxantrone—sarcoma	0.00105	0.0058	CcSEcCtD
Tranylcypromine—Haemorrhage—Mitoxantrone—sarcoma	0.00104	0.00577	CcSEcCtD
Tranylcypromine—Hepatitis—Mitoxantrone—sarcoma	0.00104	0.00577	CcSEcCtD
Tranylcypromine—Vision blurred—Thiotepa—sarcoma	0.000989	0.00548	CcSEcCtD
Tranylcypromine—Anaemia—Thiotepa—sarcoma	0.00097	0.00537	CcSEcCtD
Tranylcypromine—Agitation—Thiotepa—sarcoma	0.000965	0.00534	CcSEcCtD
Tranylcypromine—Anaemia—Dactinomycin—sarcoma	0.000963	0.00533	CcSEcCtD
Tranylcypromine—Alopecia—Vincristine—sarcoma	0.000945	0.00523	CcSEcCtD
Tranylcypromine—Leukopenia—Thiotepa—sarcoma	0.00094	0.0052	CcSEcCtD
Tranylcypromine—Chills—Mitoxantrone—sarcoma	0.000934	0.00517	CcSEcCtD
Tranylcypromine—Leukopenia—Dactinomycin—sarcoma	0.000933	0.00516	CcSEcCtD
Tranylcypromine—Alopecia—Mitoxantrone—sarcoma	0.00092	0.0051	CcSEcCtD
Tranylcypromine—Hypertension—Thiotepa—sarcoma	0.000906	0.00502	CcSEcCtD
Tranylcypromine—Agranulocytosis—Etoposide—sarcoma	0.0009	0.00499	CcSEcCtD
Tranylcypromine—Anxiety—Thiotepa—sarcoma	0.000891	0.00493	CcSEcCtD
Tranylcypromine—Confusional state—Thiotepa—sarcoma	0.000864	0.00478	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Etoposide—sarcoma	0.000862	0.00477	CcSEcCtD
Tranylcypromine—Anaemia—Vincristine—sarcoma	0.00086	0.00476	CcSEcCtD
Tranylcypromine—Agitation—Vincristine—sarcoma	0.000855	0.00474	CcSEcCtD
Tranylcypromine—Vision blurred—Mitoxantrone—sarcoma	0.000854	0.00473	CcSEcCtD
Tranylcypromine—Oedema—Dactinomycin—sarcoma	0.00085	0.00471	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Thiotepa—sarcoma	0.000839	0.00464	CcSEcCtD
Tranylcypromine—Anaemia—Mitoxantrone—sarcoma	0.000838	0.00464	CcSEcCtD
Tranylcypromine—Tachycardia—Thiotepa—sarcoma	0.000836	0.00463	CcSEcCtD
Tranylcypromine—Leukopenia—Vincristine—sarcoma	0.000833	0.00461	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Dactinomycin—sarcoma	0.000832	0.00461	CcSEcCtD
Tranylcypromine—Anorexia—Thiotepa—sarcoma	0.000817	0.00452	CcSEcCtD
Tranylcypromine—Leukopenia—Mitoxantrone—sarcoma	0.000811	0.00449	CcSEcCtD
Tranylcypromine—Anorexia—Dactinomycin—sarcoma	0.00081	0.00449	CcSEcCtD
Tranylcypromine—Flushing—Etoposide—sarcoma	0.000804	0.00445	CcSEcCtD
Tranylcypromine—Hypertension—Vincristine—sarcoma	0.000804	0.00445	CcSEcCtD
Tranylcypromine—Hypertension—Mitoxantrone—sarcoma	0.000783	0.00433	CcSEcCtD
Tranylcypromine—Chills—Etoposide—sarcoma	0.000777	0.0043	CcSEcCtD
Tranylcypromine—Paraesthesia—Thiotepa—sarcoma	0.000769	0.00426	CcSEcCtD
Tranylcypromine—Anxiety—Mitoxantrone—sarcoma	0.000769	0.00426	CcSEcCtD
Tranylcypromine—Alopecia—Etoposide—sarcoma	0.000765	0.00424	CcSEcCtD
Tranylcypromine—Somnolence—Thiotepa—sarcoma	0.000762	0.00422	CcSEcCtD
Tranylcypromine—Oedema—Vincristine—sarcoma	0.00076	0.00421	CcSEcCtD
Tranylcypromine—Confusional state—Mitoxantrone—sarcoma	0.000746	0.00413	CcSEcCtD
Tranylcypromine—Decreased appetite—Thiotepa—sarcoma	0.000745	0.00412	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Vincristine—sarcoma	0.000744	0.00412	CcSEcCtD
Tranylcypromine—Oedema—Mitoxantrone—sarcoma	0.00074	0.0041	CcSEcCtD
Tranylcypromine—Decreased appetite—Dactinomycin—sarcoma	0.000739	0.00409	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Vincristine—sarcoma	0.000734	0.00407	CcSEcCtD
Tranylcypromine—Pain—Thiotepa—sarcoma	0.000733	0.00406	CcSEcCtD
Tranylcypromine—Constipation—Thiotepa—sarcoma	0.000733	0.00406	CcSEcCtD
Tranylcypromine—Shock—Mitoxantrone—sarcoma	0.000728	0.00403	CcSEcCtD
Tranylcypromine—Pain—Dactinomycin—sarcoma	0.000727	0.00403	CcSEcCtD
Tranylcypromine—Muscle spasms—Etoposide—sarcoma	0.000725	0.00401	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Mitoxantrone—sarcoma	0.000724	0.00401	CcSEcCtD
Tranylcypromine—Anorexia—Vincristine—sarcoma	0.000724	0.00401	CcSEcCtD
Tranylcypromine—Tachycardia—Mitoxantrone—sarcoma	0.000722	0.004	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Mitoxantrone—sarcoma	0.000715	0.00396	CcSEcCtD
Tranylcypromine—Hypotension—Vincristine—sarcoma	0.00071	0.00393	CcSEcCtD
Tranylcypromine—Feeling abnormal—Thiotepa—sarcoma	0.000706	0.00391	CcSEcCtD
Tranylcypromine—Anorexia—Mitoxantrone—sarcoma	0.000705	0.00391	CcSEcCtD
Tranylcypromine—Feeling abnormal—Dactinomycin—sarcoma	0.000701	0.00388	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Thiotepa—sarcoma	0.000701	0.00388	CcSEcCtD
Tranylcypromine—Anaemia—Etoposide—sarcoma	0.000697	0.00386	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Dactinomycin—sarcoma	0.000695	0.00385	CcSEcCtD
Tranylcypromine—Hypotension—Mitoxantrone—sarcoma	0.000691	0.00383	CcSEcCtD
Tranylcypromine—Insomnia—Vincristine—sarcoma	0.000687	0.0038	CcSEcCtD
Tranylcypromine—Paraesthesia—Vincristine—sarcoma	0.000682	0.00378	CcSEcCtD
Tranylcypromine—Urticaria—Thiotepa—sarcoma	0.000681	0.00377	CcSEcCtD
Tranylcypromine—Body temperature increased—Thiotepa—sarcoma	0.000677	0.00375	CcSEcCtD
Tranylcypromine—Abdominal pain—Thiotepa—sarcoma	0.000677	0.00375	CcSEcCtD
Tranylcypromine—Leukopenia—Etoposide—sarcoma	0.000675	0.00374	CcSEcCtD
Tranylcypromine—Abdominal pain—Dactinomycin—sarcoma	0.000672	0.00372	CcSEcCtD
Tranylcypromine—Body temperature increased—Dactinomycin—sarcoma	0.000672	0.00372	CcSEcCtD
Tranylcypromine—Paraesthesia—Mitoxantrone—sarcoma	0.000664	0.00368	CcSEcCtD
Tranylcypromine—Loss of consciousness—Etoposide—sarcoma	0.000663	0.00367	CcSEcCtD
Tranylcypromine—Decreased appetite—Vincristine—sarcoma	0.00066	0.00366	CcSEcCtD
Tranylcypromine—Ataxia—Epirubicin—sarcoma	0.00066	0.00365	CcSEcCtD
Tranylcypromine—Somnolence—Mitoxantrone—sarcoma	0.000658	0.00364	CcSEcCtD
Tranylcypromine—Hypertension—Etoposide—sarcoma	0.000651	0.0036	CcSEcCtD
Tranylcypromine—Constipation—Vincristine—sarcoma	0.00065	0.0036	CcSEcCtD
Tranylcypromine—Pain—Vincristine—sarcoma	0.00065	0.0036	CcSEcCtD
Tranylcypromine—Decreased appetite—Mitoxantrone—sarcoma	0.000643	0.00356	CcSEcCtD
Tranylcypromine—Pain—Mitoxantrone—sarcoma	0.000633	0.0035	CcSEcCtD
Tranylcypromine—Constipation—Mitoxantrone—sarcoma	0.000633	0.0035	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Vincristine—sarcoma	0.000621	0.00344	CcSEcCtD
Tranylcypromine—Confusional state—Etoposide—sarcoma	0.00062	0.00344	CcSEcCtD
Tranylcypromine—Asthenia—Thiotepa—sarcoma	0.000615	0.0034	CcSEcCtD
Tranylcypromine—Ataxia—Doxorubicin—sarcoma	0.000611	0.00338	CcSEcCtD
Tranylcypromine—Asthenia—Dactinomycin—sarcoma	0.00061	0.00338	CcSEcCtD
Tranylcypromine—Feeling abnormal—Mitoxantrone—sarcoma	0.00061	0.00338	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000605	0.00335	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Etoposide—sarcoma	0.000602	0.00334	CcSEcCtD
Tranylcypromine—Tachycardia—Etoposide—sarcoma	0.000601	0.00333	CcSEcCtD
Tranylcypromine—Body temperature increased—Vincristine—sarcoma	0.000601	0.00333	CcSEcCtD
Tranylcypromine—Abdominal pain—Vincristine—sarcoma	0.000601	0.00333	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Etoposide—sarcoma	0.000595	0.00329	CcSEcCtD
Tranylcypromine—Urticaria—Mitoxantrone—sarcoma	0.000588	0.00325	CcSEcCtD
Tranylcypromine—Anorexia—Etoposide—sarcoma	0.000587	0.00325	CcSEcCtD
Tranylcypromine—Diarrhoea—Thiotepa—sarcoma	0.000586	0.00325	CcSEcCtD
Tranylcypromine—Body temperature increased—Mitoxantrone—sarcoma	0.000585	0.00324	CcSEcCtD
Tranylcypromine—Abdominal pain—Mitoxantrone—sarcoma	0.000585	0.00324	CcSEcCtD
Tranylcypromine—Diarrhoea—Dactinomycin—sarcoma	0.000582	0.00322	CcSEcCtD
Tranylcypromine—Hypotension—Etoposide—sarcoma	0.000575	0.00318	CcSEcCtD
Tranylcypromine—Dizziness—Thiotepa—sarcoma	0.000566	0.00314	CcSEcCtD
Tranylcypromine—Pollakiuria—Epirubicin—sarcoma	0.00056	0.0031	CcSEcCtD
Tranylcypromine—Paraesthesia—Etoposide—sarcoma	0.000553	0.00306	CcSEcCtD
Tranylcypromine—Somnolence—Etoposide—sarcoma	0.000547	0.00303	CcSEcCtD
Tranylcypromine—Asthenia—Vincristine—sarcoma	0.000545	0.00302	CcSEcCtD
Tranylcypromine—Vomiting—Thiotepa—sarcoma	0.000545	0.00302	CcSEcCtD
Tranylcypromine—Drowsiness—Epirubicin—sarcoma	0.000541	0.00299	CcSEcCtD
Tranylcypromine—Vomiting—Dactinomycin—sarcoma	0.000541	0.00299	CcSEcCtD
Tranylcypromine—Rash—Thiotepa—sarcoma	0.00054	0.00299	CcSEcCtD
Tranylcypromine—Dermatitis—Thiotepa—sarcoma	0.00054	0.00299	CcSEcCtD
Tranylcypromine—Headache—Thiotepa—sarcoma	0.000537	0.00297	CcSEcCtD
Tranylcypromine—Rash—Dactinomycin—sarcoma	0.000536	0.00297	CcSEcCtD
Tranylcypromine—Decreased appetite—Etoposide—sarcoma	0.000535	0.00296	CcSEcCtD
Tranylcypromine—Asthenia—Mitoxantrone—sarcoma	0.000531	0.00294	CcSEcCtD
Tranylcypromine—Constipation—Etoposide—sarcoma	0.000526	0.00291	CcSEcCtD
Tranylcypromine—Pain—Etoposide—sarcoma	0.000526	0.00291	CcSEcCtD
Tranylcypromine—Diarrhoea—Vincristine—sarcoma	0.00052	0.00288	CcSEcCtD
Tranylcypromine—Sweating—Epirubicin—sarcoma	0.000518	0.00287	CcSEcCtD
Tranylcypromine—Pollakiuria—Doxorubicin—sarcoma	0.000518	0.00287	CcSEcCtD
Tranylcypromine—Nausea—Thiotepa—sarcoma	0.000509	0.00282	CcSEcCtD
Tranylcypromine—Feeling abnormal—Etoposide—sarcoma	0.000507	0.00281	CcSEcCtD
Tranylcypromine—Diarrhoea—Mitoxantrone—sarcoma	0.000506	0.0028	CcSEcCtD
Tranylcypromine—Nausea—Dactinomycin—sarcoma	0.000505	0.0028	CcSEcCtD
Tranylcypromine—Agranulocytosis—Epirubicin—sarcoma	0.000505	0.00279	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Etoposide—sarcoma	0.000503	0.00279	CcSEcCtD
Tranylcypromine—Dizziness—Vincristine—sarcoma	0.000502	0.00278	CcSEcCtD
Tranylcypromine—Drowsiness—Doxorubicin—sarcoma	0.0005	0.00277	CcSEcCtD
Tranylcypromine—Bradycardia—Epirubicin—sarcoma	0.000494	0.00274	CcSEcCtD
Tranylcypromine—Urticaria—Etoposide—sarcoma	0.000489	0.00271	CcSEcCtD
Tranylcypromine—Haemoglobin—Epirubicin—sarcoma	0.000488	0.0027	CcSEcCtD
Tranylcypromine—Body temperature increased—Etoposide—sarcoma	0.000486	0.00269	CcSEcCtD
Tranylcypromine—Abdominal pain—Etoposide—sarcoma	0.000486	0.00269	CcSEcCtD
Tranylcypromine—Hepatitis—Epirubicin—sarcoma	0.000486	0.00269	CcSEcCtD
Tranylcypromine—Haemorrhage—Epirubicin—sarcoma	0.000486	0.00269	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Epirubicin—sarcoma	0.000483	0.00268	CcSEcCtD
Tranylcypromine—Vomiting—Vincristine—sarcoma	0.000483	0.00267	CcSEcCtD
Tranylcypromine—Sweating—Doxorubicin—sarcoma	0.00048	0.00266	CcSEcCtD
Tranylcypromine—Rash—Vincristine—sarcoma	0.000479	0.00265	CcSEcCtD
Tranylcypromine—Dermatitis—Vincristine—sarcoma	0.000479	0.00265	CcSEcCtD
Tranylcypromine—Headache—Vincristine—sarcoma	0.000476	0.00264	CcSEcCtD
Tranylcypromine—Vomiting—Mitoxantrone—sarcoma	0.00047	0.0026	CcSEcCtD
Tranylcypromine—Agranulocytosis—Doxorubicin—sarcoma	0.000467	0.00259	CcSEcCtD
Tranylcypromine—Rash—Mitoxantrone—sarcoma	0.000466	0.00258	CcSEcCtD
Tranylcypromine—Dermatitis—Mitoxantrone—sarcoma	0.000466	0.00258	CcSEcCtD
Tranylcypromine—Headache—Mitoxantrone—sarcoma	0.000463	0.00257	CcSEcCtD
Tranylcypromine—Bradycardia—Doxorubicin—sarcoma	0.000457	0.00253	CcSEcCtD
Tranylcypromine—Tinnitus—Epirubicin—sarcoma	0.000453	0.00251	CcSEcCtD
Tranylcypromine—Haemoglobin—Doxorubicin—sarcoma	0.000452	0.0025	CcSEcCtD
Tranylcypromine—Nausea—Vincristine—sarcoma	0.000451	0.0025	CcSEcCtD
Tranylcypromine—Flushing—Epirubicin—sarcoma	0.000451	0.0025	CcSEcCtD
Tranylcypromine—Hepatitis—Doxorubicin—sarcoma	0.000449	0.00249	CcSEcCtD
Tranylcypromine—Haemorrhage—Doxorubicin—sarcoma	0.000449	0.00249	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Doxorubicin—sarcoma	0.000447	0.00248	CcSEcCtD
Tranylcypromine—Asthenia—Etoposide—sarcoma	0.000442	0.00244	CcSEcCtD
Tranylcypromine—Nausea—Mitoxantrone—sarcoma	0.000439	0.00243	CcSEcCtD
Tranylcypromine—Chills—Epirubicin—sarcoma	0.000436	0.00241	CcSEcCtD
Tranylcypromine—Alopecia—Epirubicin—sarcoma	0.000429	0.00238	CcSEcCtD
Tranylcypromine—Diarrhoea—Etoposide—sarcoma	0.000421	0.00233	CcSEcCtD
Tranylcypromine—Tinnitus—Doxorubicin—sarcoma	0.000419	0.00232	CcSEcCtD
Tranylcypromine—Flushing—Doxorubicin—sarcoma	0.000417	0.00231	CcSEcCtD
Tranylcypromine—Dizziness—Etoposide—sarcoma	0.000407	0.00225	CcSEcCtD
Tranylcypromine—Muscle spasms—Epirubicin—sarcoma	0.000406	0.00225	CcSEcCtD
Tranylcypromine—Chills—Doxorubicin—sarcoma	0.000403	0.00223	CcSEcCtD
Tranylcypromine—Vision blurred—Epirubicin—sarcoma	0.000398	0.00221	CcSEcCtD
Tranylcypromine—Alopecia—Doxorubicin—sarcoma	0.000397	0.0022	CcSEcCtD
Tranylcypromine—Vomiting—Etoposide—sarcoma	0.000391	0.00217	CcSEcCtD
Tranylcypromine—Anaemia—Epirubicin—sarcoma	0.000391	0.00216	CcSEcCtD
Tranylcypromine—Agitation—Epirubicin—sarcoma	0.000388	0.00215	CcSEcCtD
Tranylcypromine—Rash—Etoposide—sarcoma	0.000388	0.00215	CcSEcCtD
Tranylcypromine—Dermatitis—Etoposide—sarcoma	0.000388	0.00215	CcSEcCtD
Tranylcypromine—Headache—Etoposide—sarcoma	0.000385	0.00213	CcSEcCtD
Tranylcypromine—Syncope—Epirubicin—sarcoma	0.000379	0.0021	CcSEcCtD
Tranylcypromine—Leukopenia—Epirubicin—sarcoma	0.000378	0.0021	CcSEcCtD
Tranylcypromine—Muscle spasms—Doxorubicin—sarcoma	0.000376	0.00208	CcSEcCtD
Tranylcypromine—Palpitations—Epirubicin—sarcoma	0.000373	0.00207	CcSEcCtD
Tranylcypromine—Loss of consciousness—Epirubicin—sarcoma	0.000371	0.00206	CcSEcCtD
Tranylcypromine—Vision blurred—Doxorubicin—sarcoma	0.000369	0.00204	CcSEcCtD
Tranylcypromine—Nausea—Etoposide—sarcoma	0.000366	0.00202	CcSEcCtD
Tranylcypromine—Hypertension—Epirubicin—sarcoma	0.000365	0.00202	CcSEcCtD
Tranylcypromine—Anaemia—Doxorubicin—sarcoma	0.000361	0.002	CcSEcCtD
Tranylcypromine—Agitation—Doxorubicin—sarcoma	0.000359	0.00199	CcSEcCtD
Tranylcypromine—Anxiety—Epirubicin—sarcoma	0.000359	0.00199	CcSEcCtD
Tranylcypromine—Dry mouth—Epirubicin—sarcoma	0.000352	0.00195	CcSEcCtD
Tranylcypromine—Syncope—Doxorubicin—sarcoma	0.000351	0.00194	CcSEcCtD
Tranylcypromine—Leukopenia—Doxorubicin—sarcoma	0.00035	0.00194	CcSEcCtD
Tranylcypromine—Confusional state—Epirubicin—sarcoma	0.000348	0.00193	CcSEcCtD
Tranylcypromine—Palpitations—Doxorubicin—sarcoma	0.000346	0.00191	CcSEcCtD
Tranylcypromine—Oedema—Epirubicin—sarcoma	0.000345	0.00191	CcSEcCtD
Tranylcypromine—Loss of consciousness—Doxorubicin—sarcoma	0.000344	0.0019	CcSEcCtD
Tranylcypromine—Shock—Epirubicin—sarcoma	0.000339	0.00188	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Epirubicin—sarcoma	0.000338	0.00187	CcSEcCtD
Tranylcypromine—Hypertension—Doxorubicin—sarcoma	0.000338	0.00187	CcSEcCtD
Tranylcypromine—Tachycardia—Epirubicin—sarcoma	0.000337	0.00186	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Epirubicin—sarcoma	0.000333	0.00185	CcSEcCtD
Tranylcypromine—Anxiety—Doxorubicin—sarcoma	0.000332	0.00184	CcSEcCtD
Tranylcypromine—Anorexia—Epirubicin—sarcoma	0.000329	0.00182	CcSEcCtD
Tranylcypromine—Dry mouth—Doxorubicin—sarcoma	0.000326	0.0018	CcSEcCtD
Tranylcypromine—Hypotension—Epirubicin—sarcoma	0.000322	0.00178	CcSEcCtD
Tranylcypromine—Confusional state—Doxorubicin—sarcoma	0.000322	0.00178	CcSEcCtD
Tranylcypromine—Oedema—Doxorubicin—sarcoma	0.000319	0.00177	CcSEcCtD
Tranylcypromine—Shock—Doxorubicin—sarcoma	0.000314	0.00174	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Doxorubicin—sarcoma	0.000312	0.00173	CcSEcCtD
Tranylcypromine—Insomnia—Epirubicin—sarcoma	0.000312	0.00173	CcSEcCtD
Tranylcypromine—Tachycardia—Doxorubicin—sarcoma	0.000311	0.00172	CcSEcCtD
Tranylcypromine—Paraesthesia—Epirubicin—sarcoma	0.00031	0.00172	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Doxorubicin—sarcoma	0.000309	0.00171	CcSEcCtD
Tranylcypromine—Somnolence—Epirubicin—sarcoma	0.000307	0.0017	CcSEcCtD
Tranylcypromine—Anorexia—Doxorubicin—sarcoma	0.000304	0.00168	CcSEcCtD
Tranylcypromine—Decreased appetite—Epirubicin—sarcoma	0.0003	0.00166	CcSEcCtD
Tranylcypromine—Hypotension—Doxorubicin—sarcoma	0.000298	0.00165	CcSEcCtD
Tranylcypromine—Constipation—Epirubicin—sarcoma	0.000295	0.00163	CcSEcCtD
Tranylcypromine—Pain—Epirubicin—sarcoma	0.000295	0.00163	CcSEcCtD
Tranylcypromine—Insomnia—Doxorubicin—sarcoma	0.000289	0.0016	CcSEcCtD
Tranylcypromine—Paraesthesia—Doxorubicin—sarcoma	0.000287	0.00159	CcSEcCtD
Tranylcypromine—Feeling abnormal—Epirubicin—sarcoma	0.000284	0.00157	CcSEcCtD
Tranylcypromine—Somnolence—Doxorubicin—sarcoma	0.000284	0.00157	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Epirubicin—sarcoma	0.000282	0.00156	CcSEcCtD
Tranylcypromine—Decreased appetite—Doxorubicin—sarcoma	0.000277	0.00154	CcSEcCtD
Tranylcypromine—Urticaria—Epirubicin—sarcoma	0.000274	0.00152	CcSEcCtD
Tranylcypromine—Pain—Doxorubicin—sarcoma	0.000273	0.00151	CcSEcCtD
Tranylcypromine—Constipation—Doxorubicin—sarcoma	0.000273	0.00151	CcSEcCtD
Tranylcypromine—Abdominal pain—Epirubicin—sarcoma	0.000273	0.00151	CcSEcCtD
Tranylcypromine—Body temperature increased—Epirubicin—sarcoma	0.000273	0.00151	CcSEcCtD
Tranylcypromine—Feeling abnormal—Doxorubicin—sarcoma	0.000263	0.00146	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000261	0.00145	CcSEcCtD
Tranylcypromine—Urticaria—Doxorubicin—sarcoma	0.000254	0.0014	CcSEcCtD
Tranylcypromine—Body temperature increased—Doxorubicin—sarcoma	0.000252	0.0014	CcSEcCtD
Tranylcypromine—Abdominal pain—Doxorubicin—sarcoma	0.000252	0.0014	CcSEcCtD
Tranylcypromine—CYP2A6—seminal vesicle—sarcoma	0.000248	0.051	CbGeAlD
Tranylcypromine—Asthenia—Epirubicin—sarcoma	0.000247	0.00137	CcSEcCtD
Tranylcypromine—Diarrhoea—Epirubicin—sarcoma	0.000236	0.00131	CcSEcCtD
Tranylcypromine—Asthenia—Doxorubicin—sarcoma	0.000229	0.00127	CcSEcCtD
Tranylcypromine—Dizziness—Epirubicin—sarcoma	0.000228	0.00126	CcSEcCtD
Tranylcypromine—Vomiting—Epirubicin—sarcoma	0.000219	0.00121	CcSEcCtD
Tranylcypromine—Diarrhoea—Doxorubicin—sarcoma	0.000218	0.00121	CcSEcCtD
Tranylcypromine—Rash—Epirubicin—sarcoma	0.000217	0.0012	CcSEcCtD
Tranylcypromine—Dermatitis—Epirubicin—sarcoma	0.000217	0.0012	CcSEcCtD
Tranylcypromine—Headache—Epirubicin—sarcoma	0.000216	0.0012	CcSEcCtD
Tranylcypromine—Dizziness—Doxorubicin—sarcoma	0.000211	0.00117	CcSEcCtD
Tranylcypromine—Nausea—Epirubicin—sarcoma	0.000205	0.00113	CcSEcCtD
Tranylcypromine—Vomiting—Doxorubicin—sarcoma	0.000203	0.00112	CcSEcCtD
Tranylcypromine—MAOB—myometrium—sarcoma	0.000203	0.0417	CbGeAlD
Tranylcypromine—Rash—Doxorubicin—sarcoma	0.000201	0.00111	CcSEcCtD
Tranylcypromine—Dermatitis—Doxorubicin—sarcoma	0.000201	0.00111	CcSEcCtD
Tranylcypromine—Headache—Doxorubicin—sarcoma	0.0002	0.00111	CcSEcCtD
Tranylcypromine—MAOB—embryo—sarcoma	0.000195	0.0401	CbGeAlD
Tranylcypromine—CYP2C9—mammary gland—sarcoma	0.000193	0.0397	CbGeAlD
Tranylcypromine—Nausea—Doxorubicin—sarcoma	0.00019	0.00105	CcSEcCtD
Tranylcypromine—MAOB—seminal vesicle—sarcoma	0.000183	0.0377	CbGeAlD
Tranylcypromine—MAOB—hematopoietic system—sarcoma	0.000174	0.0358	CbGeAlD
Tranylcypromine—MAOA—myometrium—sarcoma	0.000173	0.0356	CbGeAlD
Tranylcypromine—MAOB—connective tissue—sarcoma	0.000168	0.0345	CbGeAlD
Tranylcypromine—MAOA—embryo—sarcoma	0.000166	0.0342	CbGeAlD
Tranylcypromine—MAOA—seminal vesicle—sarcoma	0.000156	0.0321	CbGeAlD
Tranylcypromine—CYP2C19—hematopoietic system—sarcoma	0.000152	0.0312	CbGeAlD
Tranylcypromine—MAOA—hematopoietic system—sarcoma	0.000148	0.0305	CbGeAlD
Tranylcypromine—MAOA—connective tissue—sarcoma	0.000143	0.0294	CbGeAlD
Tranylcypromine—MAOB—cardiac atrium—sarcoma	0.000132	0.0272	CbGeAlD
Tranylcypromine—MAOB—uterus—sarcoma	0.000131	0.027	CbGeAlD
Tranylcypromine—CYP1A2—hematopoietic system—sarcoma	0.000124	0.0255	CbGeAlD
Tranylcypromine—CYP2A6—liver—sarcoma	0.000122	0.0251	CbGeAlD
Tranylcypromine—CYP2C9—hematopoietic system—sarcoma	0.000118	0.0242	CbGeAlD
Tranylcypromine—CYP2E1—seminal vesicle—sarcoma	0.000117	0.0241	CbGeAlD
Tranylcypromine—MAOB—tendon—sarcoma	0.000115	0.0237	CbGeAlD
Tranylcypromine—MAOA—cardiac atrium—sarcoma	0.000113	0.0232	CbGeAlD
Tranylcypromine—MAOA—uterus—sarcoma	0.000112	0.0231	CbGeAlD
Tranylcypromine—CYP2E1—hematopoietic system—sarcoma	0.000111	0.0229	CbGeAlD
Tranylcypromine—MAOA—tendon—sarcoma	9.82e-05	0.0202	CbGeAlD
Tranylcypromine—MAOB—testis—sarcoma	9.53e-05	0.0196	CbGeAlD
Tranylcypromine—MAOB—liver—sarcoma	9.01e-05	0.0185	CbGeAlD
Tranylcypromine—CYP3A4—hematopoietic system—sarcoma	8.96e-05	0.0184	CbGeAlD
Tranylcypromine—CYP2D6—hematopoietic system—sarcoma	8.82e-05	0.0181	CbGeAlD
Tranylcypromine—MAOA—testis—sarcoma	8.13e-05	0.0167	CbGeAlD
Tranylcypromine—CYP2C19—liver—sarcoma	7.86e-05	0.0162	CbGeAlD
Tranylcypromine—CYP2E1—lymphoid tissue—sarcoma	7.84e-05	0.0161	CbGeAlD
Tranylcypromine—MAOA—liver—sarcoma	7.69e-05	0.0158	CbGeAlD
Tranylcypromine—CYP2E1—tendon—sarcoma	7.37e-05	0.0152	CbGeAlD
Tranylcypromine—MAOB—lymph node—sarcoma	6.91e-05	0.0142	CbGeAlD
Tranylcypromine—CYP1A2—liver—sarcoma	6.42e-05	0.0132	CbGeAlD
Tranylcypromine—CYP2E1—testis—sarcoma	6.1e-05	0.0126	CbGeAlD
Tranylcypromine—CYP2C9—liver—sarcoma	6.09e-05	0.0125	CbGeAlD
Tranylcypromine—MAOA—lymph node—sarcoma	5.9e-05	0.0121	CbGeAlD
Tranylcypromine—CYP2E1—liver—sarcoma	5.77e-05	0.0119	CbGeAlD
Tranylcypromine—CYP2D6—testis—sarcoma	4.83e-05	0.00994	CbGeAlD
Tranylcypromine—CYP3A4—liver—sarcoma	4.64e-05	0.00955	CbGeAlD
Tranylcypromine—CYP2D6—liver—sarcoma	4.57e-05	0.0094	CbGeAlD
